While additional research is necessary to explore the potential role of GLP-1Rs expressed outside of the beta cell, including within the enteric and peripheral nervous systems, in enhancing beta cell function through enteral glucose mediation, current evidence indicates that the central nervous system (CNS) GLP-1Rs are not essential for the physiological regulation of blood sugar levels by endogenous GLP-1 or the pharmacological control of glucose homeostasis dependent on GLP-1Rs
Can be safely combined with other recovery therapies such as cryotherapy , infrared sauna , red-light therapy , or NAD+ for amplified results
MOTS-c has been shown to protect against oxidative stress , improve cellular resilience, and extend healthy lifespan in animal studies
Additionally, non-insulinotropic effects like regulating the survival and proliferation of pancreatic beta cells can be facilitated by GIP receptor activation [64, 65]
#PharmaceuticalInnovation #ObesityTreatment #ClinicalTrials To view or add a comment, sign in ORFORGLIPRON IS A PARTIAL GLP-1 AGONIST MOLECULE Q-1) If its Partial, isnt it just a weaker, inferior Drug